Literature DB >> 21841919

Identifying opportunities for a medical group to improve outcomes for patients with coronary artery disease and heart failure: an exploratory study.

Courtney Jordan Baechler1, Thomas E Kottke.   

Abstract

CONTEXT: A decision-support tool was created to identify opportunities to improve outcomes for patients with coronary artery disease and heart failure by delivering all efficacious interventions; that is, "optimizing" care. When national data were applied, nearly 75% of the deaths that could be prevented or postponed by optimizing care for patients with heart disease would occur among ambulatory patients.
OBJECTIVE: The purpose of this analysis is two-fold: 1) to determine whether medical group data are adequate to use in the decision-support tool, and 2) to determine whether the conclusions generated from the medical group data are similar to the conclusions generated from US data. DESIGN/MAIN OUTCOME MEASURE: The potential impact of optimizing care for patients age 40 to 75 years treated for coronary artery disease and heart failure by a multispecialty group between August 2007 and July 2008 was calculated using deaths that might be prevented or postponed if optimal care was achieved.
RESULTS: The greatest opportunity to prevent or postpone deaths-70% of the total opportunity-lies with optimizing care for ambulatory patients. Optimizing care for patients hospitalized for acute myocardial infarction with or without ST-segment elevation on electrocardiography would prevent or postpone only 2% of deaths.
CONCLUSIONS: This study demonstrates that 1) it is feasible to use the decision-support tool to analyze opportunities for improvement in a medical group, and 2) as concluded from national data analysis, optimizing ambulatory care presents the greatest opportunity to improve outcomes for patients with heart disease.

Entities:  

Year:  2011        PMID: 21841919      PMCID: PMC3140747          DOI: 10.7812/TPP/11-012

Source DB:  PubMed          Journal:  Perm J        ISSN: 1552-5767


  28 in total

1.  Explanation for the decline in coronary heart disease mortality rates in Auckland, New Zealand, between 1982 and 1993.

Authors:  S Capewell; R Beaglehole; M Seddon; J McMurray
Journal:  Circulation       Date:  2000-09-26       Impact factor: 29.690

Review 2.  Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials.

Authors:  Rod S Taylor; Allan Brown; Shah Ebrahim; Judith Jolliffe; Hussein Noorani; Karen Rees; Becky Skidmore; James A Stone; David R Thompson; Neil Oldridge
Journal:  Am J Med       Date:  2004-05-15       Impact factor: 4.965

3.  Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients.

Authors: 
Journal:  BMJ       Date:  2002-01-12

4.  The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.

Authors:  B Pitt; F Zannad; W J Remme; R Cody; A Castaigne; A Perez; J Palensky; J Wittes
Journal:  N Engl J Med       Date:  1999-09-02       Impact factor: 91.245

Review 5.  Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review.

Authors:  Julia A Critchley; Simon Capewell
Journal:  JAMA       Date:  2003-07-02       Impact factor: 56.272

Review 6.  Invasive therapy along with glycoprotein IIb/IIIa inhibitors and intracoronary stents improves survival in non-ST-segment elevation acute coronary syndromes: a meta-analysis and review of the literature.

Authors:  Anthony A Bavry; Dharam J Kumbhani; Rene Quiroz; Suneil R Ramchandani; Satish Kenchaiah; Elliott M Antman
Journal:  Am J Cardiol       Date:  2004-04-01       Impact factor: 2.778

7.  Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000.

Authors:  Belgin Unal; Julia Alison Critchley; Simon Capewell
Journal:  Circulation       Date:  2004-03-01       Impact factor: 29.690

8.  Indications for ACE inhibitors in the early treatment of acute myocardial infarction: systematic overview of individual data from 100,000 patients in randomized trials. ACE Inhibitor Myocardial Infarction Collaborative Group.

Authors: 
Journal:  Circulation       Date:  1998-06-09       Impact factor: 29.690

Review 9.  Combined resynchronisation and implantable defibrillator therapy in left ventricular dysfunction: Bayesian network meta-analysis of randomised controlled trials.

Authors:  Simon K H Lam; Andrew Owen
Journal:  BMJ       Date:  2007-10-11

10.  Explaining the decrease in U.S. deaths from coronary disease, 1980-2000.

Authors:  Earl S Ford; Umed A Ajani; Janet B Croft; Julia A Critchley; Darwin R Labarthe; Thomas E Kottke; Wayne H Giles; Simon Capewell
Journal:  N Engl J Med       Date:  2007-06-07       Impact factor: 91.245

View more
  2 in total

1.  An algorithm that identifies coronary and heart failure events in the electronic health record.

Authors:  Thomas E Kottke; Courtney Jordan Baechler
Journal:  Prev Chronic Dis       Date:  2013       Impact factor: 2.830

2.  Accuracy of heart disease prevalence estimated from claims data compared with an electronic health record.

Authors:  Thomas E Kottke; Courtney Jordan Baechler; Emily D Parker
Journal:  Prev Chronic Dis       Date:  2012       Impact factor: 2.830

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.